PositoAI/ US/ IRADIMED CORPORATION

IRADIMED CORPORATION

NasdaqGM: IRMD · Healthcare

Positivity Index

#5,312 / 6,774

Global

#2,867 / 4,000

United States

Positivity Score

17,790

Rank→

Overview Go Deep Penta Pattern Funda News For this company Histo

PosiRed: no active red flags

IRADIMED CORPORATION — Overview & Financial Snapshot

IRADIMED CORPORATION (NasdaqGM: IRMD) is a Healthcare company, ranked #5,312 of 6,774 companies globally and #2,867 of 4,000 in United States on PositoAI, with a Positivity Score of 17,790. Its market capitalisation is ₹10,577.93 Cr ($1.12B), P/E ratio is 49.0 and P/B ratio is 11.01. It has no active red flags (PosiRed) or yellow flags (PosiYellow) on record.

For financial statements, ratio trends and score history, Go Deep →

Top-ranked Healthcare companies

#3 Dogwood Therapeutics, Inc. 27,827 #8 Impact BioMedical Inc. 26,149 #13 Onconetix, Inc. 25,902 #15 Revelation Biosciences, Inc. 25,780 #18 Vyome Holdings, Inc. 25,696

— Nothing to show —

OpenAI is reading recent news...

IRADIMED CORPORATION develops, manufactures, markets, and distributes magnetic resonance imaging (MRI) compatible intravenous infusion pump systems and MRI compatible patient vital signs monitoring systems and related accessories. The company offers MRidium 3870 and 3860+ MRI Compatible IV Infusion Pump System with associated disposable IV tubing sets; 3880 MRI compatible patient vital signs monitoring system; and 3600 FMD1 with remote alarm logging unit ferromagnetic detection device. It also provides non-magnetic IV poles, wireless remote displays/controls, side car pump modules, dose error reduction systems, and SpO2 monitoring with sensors and accessories. The company serves hospitals, acute care facilities, and outpatient imaging centers. It sells its products through direct field sales representatives, regional sales directors, clinical application specialists, and independent distributors in the United States and internationally. The company was incorporated in 1992 and is headquartered in Orlando, Florida.

P/B Ratio 11.01

P/E Ratio 49.0

D/E Ratio 0.00

ROE 23.52%

Owes vs Owns ? 0.12× Low $0.12 owed for every $1 it owns · balance sheet Jun 2026

Dividend Yield 0.91%

Trailing EPS ₹168.96$1.79

Forward EPS ₹231.57$2.45

Beta 0.91

Market Cap ₹10,577.93 Cr$1.12B

What these numbers mean →

What does IRADIMED CORPORATION do?

What is IRADIMED CORPORATION's P/E and P/B ratio?

IRADIMED CORPORATION has a P/E ratio of 49.0 and a P/B ratio of 11.01.

What is IRADIMED CORPORATION's debt-to-equity ratio?

IRADIMED CORPORATION has a debt-to-equity ratio of 0.00.

How much does IRADIMED CORPORATION owe compared with what it owns?

IRADIMED CORPORATION owes $0.12 for every $1 it owns (balance sheet Jun 2026), which is low.

What is IRADIMED CORPORATION's Positivity rank?

IRADIMED CORPORATION is ranked #5,312 of 6,774 companies globally and #2,867 of 4,000 in United States on PositoAI, with a Positivity Score of 17,790.

Does IRADIMED CORPORATION have any regulatory orders, red flags (PosiRed) or yellow flags (PosiYellow)?

No active red flags (PosiRed) or yellow flags (PosiYellow) are currently on record for IRADIMED CORPORATION.

Where can I read the latest news about IRADIMED CORPORATION?

Recent headlines about IRADIMED CORPORATION from the last 30 days, with links to the original articles, are on its News page on PositoAI.

Does IRADIMED CORPORATION have a PositoAI PosiShot or QR code?

Yes. A dated PosiShot of IRADIMED CORPORATION's current position, a PosiQR code for its live profile and a ready-made dated mention are available on its For this company page on PositoAI.

0 / 1000

🔒 Private — stored only in this browser, never sent to PositoAI. Clear anytime in Settings.